Biomaterial Database

The effects of adrenergic-blocking agents on the pulmonary circulation in man. 1956

J MACKINNON, and C F VICKERS, and E G WADE

UI	MeSH Term	Description	Entries
D008297	Male		Males
D011652	Pulmonary Circulation	The circulation of the BLOOD through the LUNGS.	Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D001775	Blood Circulation	The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.	Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D002317	Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.	Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D004876	Ergot Alkaloids	Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.	Clavine Alkaloids,Alkaloids, Clavine,Alkaloids, Ergot
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013565	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.	Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents
D018674	Adrenergic Antagonists	Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.	Adrenergic-Blocking Agents,Adrenolytics,Antiadrenergic Agents,Adrenergic Antagonist,Adrenergic Blockaders,Adrenergic Blocker,Adrenergic Blockers,Adrenergic Receptor Antagonists,Adrenergic Receptor Blockaders,Adrenolytic Agents,Adrenolytic Drugs,Anti-Adrenergics,Antiadrenergics,Receptor Antagonists, Adrenergic,Adrenergic Blocking Agents,Agents, Adrenergic-Blocking,Agents, Adrenolytic,Agents, Antiadrenergic,Antagonist, Adrenergic,Antagonists, Adrenergic,Antagonists, Adrenergic Receptor,Anti Adrenergics,Blockaders, Adrenergic,Blockaders, Adrenergic Receptor,Blocker, Adrenergic,Blockers, Adrenergic,Drugs, Adrenolytic,Receptor Blockaders, Adrenergic